NCT05217797View on ClinicalTrials.gov

Glasses Against Transmission of SARS-CoV-2 (COVID-19) in the Community

NACompletedINTERVENTIONAL
Enrollment

3,717

Participants

Timeline

Start Date

February 2, 2021

Primary Completion Date

May 1, 2022

Study Completion Date

December 1, 2022

Conditions
COVID-19Respiratory Tract Infections
Interventions
BEHAVIORAL

Wearing glasses (any type)

Participants are asked to wear glasses in public spaces.

Trial Locations (1)

0213

Norwegian Institute of Public Health, Oslo

All Listed Sponsors
collaborator

University of Basel

OTHER

lead

Norwegian Institute of Public Health

OTHER_GOV

NCT05217797 - Glasses Against Transmission of SARS-CoV-2 (COVID-19) in the Community | Biotech Hunter | Biotech Hunter